DossierENTITY

antibody-drug conjugate

Coverage of antibody-drug conjugate in the Nexus archive.

Earliest in view: Jul 6 · 12:56 UTCMost recent: Jul 6 · 12:56 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 6 · 12:56 UTCSTAT NEWS
STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and more
Novartis acquired Myricx Bio for $1.1 billion to advance its antibody-drug conjugate (ADC) pipeline with a novel NMTi payload. Congressional Republicans passed a bill funding the FDA, including a report urging the agency to implement requirements for diversifying clinical trials.